home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  October 20, 2017
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[1] [3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 592 active entries

Immunitor Inc.

365-2906 West Broadway
Vancouver V6K 2G8

Phone: 1 301 4760930
Fax: 1-775-640-6636 (USA)
E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it


Immunitor Inc (Company) is incorporated in 2010 in Vancouver, Canada as licensee of Immunitor USA Inc., incorporated in 2004 in Maryland, USA. The Company has exclusive rights to in-house developed products and currently manufactures six immunotherapies as means of preventing and/or treating viral (V1), bacterial (V2), fungal (V4) infections; chronic hepatits B and C (V5), atherosclerosis (V6), tuberculosis (V7) and cancer (V3). The latest immunotherapy, hepcortespenlisimut-L, received orphan drug designation form the US FDA in 2014 and is currently in phase III clinical trial for liver cancer designation. The licensed technology is unique since it enables to formulate any protein or vaccine (recombinant or from natural source) as an oral pill, which is easy to administer, has low manufacturing cost, stable, safe, and effective. No other technology exists that could compete with Immunitor’s breakthrough invention which will reshape the vaccine and therapeutic protein industry.  

Selected Categories:

Product Company   Service Company
- General
- General
- Distributor
- General
- Production

Last update of this entry: February 02, 2016

Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.